LAS VEGAS – GVB Biopharma, a pharmaceutical company specializing in hemp and cannabis-related consumer products, announced today that it has established the process and infrastructure for producing medicinal products from cannabigerol (CBG).  With this venture, GVB Biopharma creates a scientific foundation and professional network for a research and development program for CBG, allowing for the …

Read moreGVB Biopharma Begins Cannabigerol (CBG) Studies to Assess Therapeutic Potential